FDA-approved Alzheimer's drug lecanemab could prevent free-floating amyloid beta fibrils from damaging the brain
For the first time, researchers described the structure of a special type of amyloid beta plaque protein associated with Alzheimer's disease (AD) progression. In a report published May 10 in the journal Neuron, scientists ...
May 10, 2023
0
92